Medicare and telehealth: more restrictive rules could hit patients in 2025
Congress recently pulled a similar stunt on Medicare beneficiaries. But in this case, the result was more than just ...
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
US Proposes $21 Billion Medicare Payment Boost to Insurers
Health insurance companies selling private Medicare Advantage plans in the US would see a greater increase in payments in ...
US proposes payment rate for 2026 Medicare Advantage insurers
The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...
Medicare caps seniors drug expenses: What you need to know
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Here We Go Again: The Medicare Advantage Open Enrollment Period
The Medicare Advantage Open Enrollment Period (Jan 1–Mar 31) lets you switch plans or adjust coverage. Review your options to ...
Center on Budget and Policy Priorities1 天
Growth in Medicare Advantage Raises Concerns
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...
I’m blindsided by extra Medicare charges because of my income. How do I avoid this situation?
A reader is trying to plan ahead to avoid the dreaded surcharges that can come out of your Social Security check.
Medicare扩大肾移植检测覆盖范围
加利福尼亚州尔湾 - 市值目前为3800万美元的分子诊断公司Oncocyte Corp. (NASDAQ: OCX)宣布,其VitaGraft Kidney肾移植患者检测获得了Medicare扩大覆盖范围。这一决定源于一项研究表明该检测在早期发现移植排斥反应方面的有效性。根据 InvestingPro 的数据,尽管公司面临重大运营挑战,但其股票目前的交易价格接近其公允价值。分子诊断计划 ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
Chattanooga Times Free Press16 小时
Contact your local congressperson for help with Social Security/Medicare
Toni, Last week's Medicare Part D question was from Tonya regarding discovering that she and her husband are receiving an ...
Castle Biosciences股价因Medicare拒绝承保而下跌
Investing.com -- Castle Biosciences (NASDAQ:CSTL)股价下跌9%，此前地区Medicare承包商Novitas最终决定不承保该公司的一项癌症检测。Novitas Medicare行政承包商 (MAC)确认了一项地方承保决定 (LCD)，导致不承保Castle的DecisionDx-SCC检测。这一决定将于2月23日生效。